Rejoni is a privately held medical technology company designing and developing hydrogels to improve the standard of care in Women’s Health.
Location: United States
Total raised: $50M
Investors 1
| Date | Name | Website |
| 16.12.2022 | Catalyst H... | chv.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.06.2026 | - | $25M | Ascension ... |
| 07.12.2022 | Series B | $25M | - |
Mentions in press and media 8
| Date | Title | Description |
| 18.06.2026 | Rejoni Secures $25M for Uterine Health Innovation, Juveena System Nears Launch | Rejoni, a leading women's health company, secured $25 million. This substantial financing fuels the advanced development and market introduction of its Juveena Hydrogel System. Juveena aims to revolutionize uterine healing. It targets the r... |
| 16.06.2026 | Rejoni Raises $25M in Funding | Rejoni, Inc., a Bedford, MA-based clinical-stage company which specializes in uterine health, raised $25M in funding. Backers included Clavyst Bio, Amed Ventures, Ascension Ventures, Catalyst Health Ventures, Delos Capital, FemHealth Ventur... |
| 16.06.2026 | Rejoni Secures $25 Million To Advance Juveena Hydrogel System Toward FDA Approval And Commercial Launch | Rejoni, a clinical-stage women’s health company focused on biomaterial therapies, announced the closing of a $25 million financing round to support the development and commercialization of the Juveena Hydrogel System. The financing included... |
| 04.02.2025 | Rejoni completes patient enrollment in pivotal clinical study of a Novel Treatment for the Prevention of Intrauterine Adhesions, the Juveena® Hydrogel System. | BEDFORD, Mass.–(BUSINESS WIRE)–February 4, 2025– Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150 patients in the Juveena Hydrogel pivotal clinical study. This announcement marks a s... |
| 07.12.2022 | Rejoni Closes $25M Series B Financing | Rejoni, a Bedford, MA-based company focused on the development and commercialization of gynecological products using its proprietary biomaterials, raised $25M in Series B funding. The round was led by Catalyst Health Ventures, with continue... |
| 14.09.2020 | Rejoni Closes $15 Million Financing | Rejoni announced today that it has closed a $15 million Series A financing. The round was led by Ascension Ventures, with additional participation from Delos Capital and Sparta Group. Rejoni is using its biomaterials expertise to realize me... |
| - | Rejoni | “Rejoni” |
| - | Rejoni | “Rejoni – Focused on helping women achieve the life they want” |